NasdaqCM - Nasdaq Real Time Price USD

Jupiter Neurosciences, Inc. (JUNS)

0.6202
-0.0148
(-2.33%)
At close: May 9 at 4:00:00 PM EDT
0.6399
+0.02
+(3.18%)
After hours: May 9 at 4:25:23 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
233.2810
638.0370
Operating Expense
3,091.2820
3,091.2820
3,870.7710
3,665.7280
4,545.1340
Operating Income
-3,091.2820
-3,091.2820
-3,870.7710
-3,432.4470
-3,907.0970
Net Non Operating Interest Income Expense
-242.8090
-242.8090
-218.2230
-740.2370
-113.8620
Other Income Expense
894.4660
894.4660
-694.6950
-784.8960
-179.3000
Pretax Income
-2,439.6250
-2,439.6250
-4,783.6890
-4,957.5800
-4,200.2590
Net Income Common Stockholders
-2,439.6250
-2,439.6250
-4,783.6890
-4,957.5800
-4,200.2590
Diluted NI Available to Com Stockholders
-2,439.6250
-2,439.6250
-4,783.6890
-4,957.5800
-4,200.2590
Basic EPS
-0.08
--
-0.18
-0.15
-0.44
Diluted EPS
-0.08
--
-0.18
-0.15
-0.44
Basic Average Shares
28,783.0450
--
26,405.1090
32,876.4130
9,486.6810
Diluted Average Shares
28,783.0450
--
26,405.1090
32,876.4130
9,486.6810
Total Operating Income as Reported
-3,091.2820
-3,091.2820
-3,870.7710
-3,432.4470
-3,907.0970
Total Expenses
3,091.2820
3,091.2820
3,870.7710
3,665.7280
4,545.1340
Net Income from Continuing & Discontinued Operation
-2,439.6250
-2,439.6250
-4,783.6890
-4,957.5800
-4,200.2590
Normalized Income
-3,244.0910
-3,244.0910
-4,044.4940
-4,172.6840
-4,020.9590
Interest Income
5.5570
5.5570
0.4820
0.6170
0.1320
Interest Expense
248.3660
248.3660
218.7050
740.8540
113.9940
Net Interest Income
-242.8090
-242.8090
-218.2230
-740.2370
-113.8620
EBIT
-2,191.2590
-2,191.2590
-4,564.9840
-4,216.7260
-4,086.2650
EBITDA
-2,191.2590
-2,191.2590
-4,564.9840
-4,216.7260
-4,086.2650
Net Income from Continuing Operation Net Minority Interest
-2,439.6250
-2,439.6250
-4,783.6890
-4,957.5800
-4,200.2590
Total Unusual Items Excluding Goodwill
804.4660
804.4660
-739.1950
-784.8960
-179.3000
Total Unusual Items
804.4660
804.4660
-739.1950
-784.8960
-179.3000
Normalized EBITDA
-2,995.7250
-2,995.7250
-3,825.7890
-3,431.8300
-3,906.9650
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 12/3/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ABP Abpro Corporation
0.2000
+3.09%
 
ONCO Onconetix, Inc.
0.0720
-1.10%
 
CELU Celularity Inc.
1.6700
-0.60%
 
ARTL Artelo Biosciences, Inc.
1.0200
+2.00%
 
OKYO OKYO Pharma Limited
1.4500
-2.03%
 
GRCE Grace Therapeutics, Inc.
2.7200
-2.86%
 
HMTXF Hemostemix Inc.
0.0668
0.00%
 
CELUW Celularity Inc.
0.0400
-4.76%
 
RKVTF RAKOVINA THERAPEUTICS INC
0.0324
-0.61%
 
VRAX Virax Biolabs Group Limited
1.0500
-0.94%